GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7%
Tue, 23 Oct

GSK PHARMA has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

GSK PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m8,3637,3578,16311.0%-2.4%
Other incomeRs m96178148-16.6%54.2%
TurnoverRs m8,4597,5348,31110.3%-1.7%
ExpensesRs m6,4425,9536,5129.4%1.1%
Gross profitRs m1,9731,3211,53416.1%-22.3%
DepreciationRs m771141151.2%48.8%
InterestRs m02210.0%0.0%
Profit before taxRs m1,9911,3831,56513.1%-21.4%
TaxRs m68849755712.0%-19.1%
Profit after taxRs m1,3038861,00813.7%-22.7%
Gross profit margin%23.618.018.8
Effective tax rate%34.635.935.6
Net profit margin%15.411.812.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 2.4% on a year-on-year (YoY) basis. The expenses were up by 1.1% YoY during the same period.
  • The company's operating profit declined by 22.3% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 18.8% in 2QFY19 as against 23.6% in 2QFY18.
  • Depreciation charges and finance costs increased by 48.8% YoY and 0.0% YoY, respectively.
  • Other income increased by 54.2% YoY during the quarter.
  • Net profit for the quarter declined by 22.7% YoY. Net profit margins during the quarter declined from 15.4% in 2QFY18 to 12.1% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 11.0% on a quarter-on-quarter (QoQ) basis. The expenses were up by 9.4% QoQ during the same period.
  • The company's operating profit increased by 16.1% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 18.8% in 2QFY19 as against 18.0% in 1QFY18.
  • Net profit for the quarter increased by 13.7% QoQ, while net profit margins increased from 11.8% in 1QFY18 to 12.1% in 2QFY19.

To see how GSK PHARMA has performed over the last eight quarters, please visit here.

GSK PHARMA Share Price Performance

Over the last one year, GSK PHARMA share price has moved up from Rs 1,217.9 to Rs 1,355.0, registering a Gain of Rs 137.1 or around 11.3%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,438.9 (down 0.5%). Over the last one year it has moved up from 14,047.3 to 14,438.9, a gain of 392 points (up 2.8%).

Overall, the S&P BSE SENSEX is up 4.6% over the year.

Current Valuations

At the current price of Rs 1,355.0, the price to earnings (P/E) ratio of GSK PHARMA stands at 59.7 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 11.2 times.

Equitymaster requests your view! Post a comment on "GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7%". Click here!

  

Related Views on News

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

How We Made 14.64% Trading Profit in Just 2 Days

Dec 12, 2019

A high probability trade that worked to perfection for my subscribers.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

Stocks that Can Outperform No Matter what the RBI Does Today(The 5 Minute Wrapup)

Dec 5, 2019

I won't be surprised if these stocks repeat their 2002-2006 performance.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Dec 16, 2019 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

MARKET STATS